Literature DB >> 31278653

Dysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21.

Hadiseh Samiei1, Bizhan Sadighi-Moghaddam2,3, Saeed Mohammadi4,5, Abdolsamad Gharavi6,7, Sara Abdolmaleki8, Ayyoob Khosravi5,9, Parviz Kokhaei2,10, Hadi Bazzazi9,11, Ali Memarian12.   

Abstract

Dysregulation of helper T (Th) cell subsets has been contributed to the initiation and propagation of esophageal squamous cell carcinoma (ESCC). Different microRNAs (miRNAs) have been reported to control the development and functions of tumor-associated immune cells in ESCC. Here, we aimed to assess the IL-10, TGF-β, IFN-γ, and IL-17a-producing CD3+CD8- T cells in association whit miR-21, miR-29b, miR-106a, and miR-155 expression in ESCC patients. A total of 34 ESCC patients including 12 newly diagnosed (ND) and 22 under-treatment (UT) cases and also 34 age-matched healthy donors were enrolled. Flow cytometric characterization of stimulated T cells was performed by staining of the cells with fluorescent conjugated specific anti-human CD3 and CD8 cell surface markers as well as IL-17a, IFN-γ, IL-10, and TGF-β intracytoplasmic cytokines. Circulating RNA was extracted from the plasma, and qRT-PCR was used to evaluate the expression of microRNAs. TGF-β plasma levels were also assessed by ELISA. Results showed that the frequency of Th cells was significantly reduced in patients. A significant increase in Treg as well as Th17 cells population in both patient subgroups was observed. ND patients showed elevated level of Th1 cells and IL-10. However the mean expression of IFN-γ was significantly decreased in Th cells. We also detected higher level of miR-21 in the ESCC patients which was significantly correlated with different subsets of Th cells. Our findings revealed that immune response related to the Th cells is highly impaired in ESCC patients. Association between miR-21 and Th subsets could be correlated with the impairment of anti-tumor immunity and ESCC pathogenesis, which could be potentially used as an important target for immunotherapeutic approaches.

Entities:  

Keywords:  Esophageal squamous cell carcinoma (ESCC); Helper T cells; Immunoregulation; miR-21; miR-29b

Mesh:

Substances:

Year:  2019        PMID: 31278653     DOI: 10.1007/s12026-019-09079-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  60 in total

1.  MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis.

Authors:  Gopal Murugaiyan; Andre Pires da Cunha; Amrendra K Ajay; Nicole Joller; Lucien P Garo; Sowmiya Kumaradevan; Nir Yosef; Vishal S Vaidya; Howard L Weiner
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 2.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

3.  miR-29b inhibits the progression of esophageal squamous cell carcinoma by targeting MMP-2.

Authors:  Y Qi; X Li; S Zhao
Journal:  Neoplasma       Date:  2015       Impact factor: 2.575

4.  MicroRNA-155 inversely correlates with esophageal cancer progression through regulating tumor-associated macrophage FGF2 expression.

Authors:  Peng Wang; Li-Juan Xu; Jie-Jie Qin; Lu Zhang; Gui-Hua Zhuang
Journal:  Biochem Biophys Res Commun       Date:  2018-06-30       Impact factor: 3.575

5.  Negative feedback regulation of IFN-gamma pathway by IFN regulatory factor 2 in esophageal cancers.

Authors:  Yan Wang; Dongping Liu; Pingping Chen; H Phillip Koeffler; Xiangjun Tong; Dong Xie
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

Review 6.  Diverse roles of miR-29 in cancer (review).

Authors:  Hesong Jiang; Guang Zhang; Jun-Hua Wu; Chun-Ping Jiang
Journal:  Oncol Rep       Date:  2014-02-20       Impact factor: 3.906

7.  Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells.

Authors:  Arnob Banerjee; Felix Schambach; Caitlin S DeJong; Scott M Hammond; Steven L Reiner
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

8.  Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.

Authors:  G Del Prete; M De Carli; F Almerigogna; M G Giudizi; R Biagiotti; S Romagnani
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

9.  Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China.

Authors:  He Liang; Jin-Hu Fan; You-Lin Qiao
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

10.  MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1.

Authors:  Rui Yao; Yu-Lan Ma; Wei Liang; Huan-Huan Li; Zhi-Jun Ma; Xian Yu; Yu-Hua Liao
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more
  10 in total

1.  The expansion of CD14+ CD163+ subpopulation of monocytes and myeloid cells-associated cytokine imbalance; candidate diagnostic biomarkers for celiac disease (CD).

Authors:  Omid Babania; Saeed Mohammadi; Esmat Yaghoubi; Ahmad Sohrabi; Fakhri Sadat Seyedhosseini; Nafiseh Abdolahi; Yaghoub Yazdani
Journal:  J Clin Lab Anal       Date:  2021-08-27       Impact factor: 2.352

2.  Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I-deficient breast cancer cells.

Authors:  Ming-Zhen Zhao; Yu Sun; Xiao-Feng Jiang; Li Liu; Li Liu; Li-Xin Sun
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

3.  Association between alcohol consumption and oesophageal microbiota in oesophageal squamous cell carcinoma.

Authors:  Wenqing Rao; Zheng Lin; Shuang Liu; Zhihui Zhang; Qianwen Xie; Huilin Chen; Xi Lin; Yuanmei Chen; Huimin Yang; Kaili Yu; Zhijian Hu
Journal:  BMC Microbiol       Date:  2021-03-06       Impact factor: 3.605

4.  Simultaneous disruption of circulating miR-21 and cytotoxic T lymphocytes (CTLs): Prospective diagnostic and prognostic markers for esophageal squamous cell carcinoma (ESCC).

Authors:  Hadiseh Samiei; Faezeh Ajam; Abdolsamad Gharavi; Sara Abdolmaleki; Parviz Kokhaei; Saeed Mohammadi; Ali Memarian
Journal:  J Clin Lab Anal       Date:  2021-11-19       Impact factor: 2.352

5.  The lower expression of circulating miR-210 and elevated serum levels of HIF-1α in ischemic stroke; Possible markers for diagnosis and disease prediction.

Authors:  Mina Rahmati; Gordon A Ferns; Naser Mobarra
Journal:  J Clin Lab Anal       Date:  2021-10-28       Impact factor: 2.352

6.  The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell Carcinoma.

Authors:  Jishuai Zhang; Haifeng Wang; Haitao Wu; Guangliang Qiang
Journal:  Biomed Res Int       Date:  2021-09-27       Impact factor: 3.411

7.  MicroRNA-21 as a potential biomarker for detecting esophageal carcinoma in Asian populations: a meta-analysis.

Authors:  Zheng Han; Lingbo Pan; Bangjie Lu; Huixia Zhu
Journal:  PeerJ       Date:  2022-09-30       Impact factor: 3.061

Review 8.  Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy.

Authors:  Yin Qianmei; Su Zehong; Wang Guang; Li Hui; Gaojian Lian
Journal:  Immunol Res       Date:  2021-07-24       Impact factor: 2.829

9.  Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction.

Authors:  Douâa Moussa Agha; Redouane Rouas; Mehdi Najar; Fatima Bouhtit; Hussein Fayyad-Kazan; Laurence Lagneaux; Dominique Bron; Nathalie Meuleman; Philippe Lewalle; Makram Merimi
Journal:  Cells       Date:  2020-09-08       Impact factor: 6.600

10.  Tumor microenvironment characterization in esophageal cancer identifies prognostic relevant immune cell subtypes and gene signatures.

Authors:  Yuhong Zhang; Minqi Zhu; Junxian Mo; Lei Xian
Journal:  Aging (Albany NY)       Date:  2021-12-26       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.